SCHEMBL17023100

SCHEMBL17023100

COc1cc(OC)c(Cl)c(-c2ccc(OC(=O)Nc3ccc(CN4CCN(C)CC4)cn3)c3nccnc23)c1Cl

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17023041 0.95 FGFR3 (0.81) FGFR3
SCHEMBL17023139 0.94 FGFR3 (0.80) FGFR3
SCHEMBL17023047 0.94 FGFR3 (0.70) FGFR3
SCHEMBL17023164 0.94 FGFR3 (0.70) FGFR3
SCHEMBL17023088 0.94 FGFR3 (0.69) FGFR3
SCHEMBL17023158 0.92 FGFR3 (0.68) FGFR3
SCHEMBL17023103 0.92 FGFR3 (0.72) FGFR3
SCHEMBL17023118 0.91 FGFR3 (0.79) FGFR3
SCHEMBL17023120 0.91 FGFR3 (0.67) FGFR3
SCHEMBL17023061 0.91 FGFR3 (0.69) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed